Context Summits, the preeminent producer of events for the alternative asset management industry, will release a detailed research report on hedge fund allocation trends in 2016 on March 30. At...

The Chemours Company ("Chemours") (NYSE: CC), a global chemistry company with leading market positions in titanium technologies, fluoroproducts and chemical solutions, today announced that Mark...

ARMO BioSciences, Inc., a clinical-stage biotechnology company, today announced that positive results from an ongoing phase 1 clinical trial of ARMO's investigational drug AM0010 (PEGylated...

Merrimack Pharmaceuticals, Inc. (Nasdaq: MACK) today announced that it will present preclinical and clinical data on its extensive oncology pipeline at the 2016 American Association for Cancer...

Celsion Corporation (NASDAQ: CLSN), an oncology drug development company, today announced that its preclinical data for GEN-1 in combination with Avastin® and Doxil® for the treatment of ovarian...